Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 8

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 8
---
 fiduciary,
contractual or other obligations or duties, he or she may be required to honor these obligations and duties to present such business combination
opportunity to such entities first, and only present it to us if such entities reject the opportunity and he or she determines to present
the opportunity to us, subject to their fiduciary duties under Cayman Islands law.

Our initial shareholders
and members of our management team may participate in the formation of, invest in (on behalf of themselves, their affiliates or its and
their clients), or become an officer or director of, any other blank check company prior to completion of our initial business combination.
As a result, our initial shareholders and members of our management team could have conflicts of interest in determining whether to present
business combination opportunities to us or to any other blank check company with which they may become involved.

Initial Business Combination

We will have up to 15 months
from the closing of the IPO to consummate an initial business combination. However, if we anticipate that we may not be able to consummate
our initial business combination within 15 months, we may, by resolution of our board of directors if requested by our sponsor, extend
the period of time we will have to consummate an initial business combination up to two times, each by an additional three months
(for a total of up to 21 months to complete an initial business combination from the closing of the IPO), subject to our sponsor
depositing into the trust account $0.10 per public share outstanding in connection with each such extension. Our shareholders will
not be entitled to vote on or redeem their shares in connection with any such extension. Pursuant to the terms of our amended and restated
memorandum and articles of association, in order to extend the period of time to consummate an initial business combination in such a
manner, our sponsor, upon no less than five days’ advance notice prior to the deadline, must deposit $0.10 per public share
outstanding in connection with each such extension into the trust account on or prior to the date of the deadline. Our sponsor is not
obligated to extend the time for us to complete our initial business combination. In the event that we receive notice from our sponsor
five days prior to the deadline of its wish for us to effect an extension, we intend to issue a press release announcing such intention
at least three days prior to the deadline. In addition, we intend